Page last updated: 2024-11-06

phentolamine and Erythrocytosis

phentolamine has been researched along with Erythrocytosis in 1 studies

Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Tymko, MM1
Lawley, JS1
Ainslie, PN1
Hansen, AB1
Hofstaetter, F1
Rainer, S1
Amin, S1
Moralez, G1
Gasho, C1
Vizcardo-Galindo, G1
Bermudez, D1
Villafuerte, FC1
Hearon, CM1

Other Studies

1 other study available for phentolamine and Erythrocytosis

ArticleYear
Global Reach 2018 Heightened α-Adrenergic Signaling Impairs Endothelial Function During Chronic Exposure to Hypobaric Hypoxia.
    Circulation research, 2020, 07-03, Volume: 127, Issue:2

    Topics: Acetylcholine; Adaptation, Physiological; Adrenergic Agents; Adult; Altitude; Altitude Sickness; Blo

2020